心脏性休克:专注于非心脏生物标志物
Hadi Beaini1, Zainali Chunawala1,2, Daniel Cheeran1,3
1Department of Medicine, The University of Texas Southwestern Medical Center, 5959 Harry Hines Blvd, Dallas, TX, 75235, USA.
Current heart failure reports
|July 30, 2024
概括
乳酸和葡萄糖等非心脏生物标志物为心脏性休克 (CS) 管理提供了新的见解. 这些标志物改善了诊断和预后,指导了对这种严重疾病的更好的患者护理.
科学领域:
- 心脏病学 心脏病学
- 生物标志物研究 生物标志物研究
- 关键护理医学 关键护理医学
背景情况:
- 心脏性休克 (CS) 是一种复杂的疾病,死亡率高.
- 标准评估侧重于心脏结构和功能.
- 在CS中需要改进风险分层和风险管理策略.
研究的目的:
- 探索非心脏生物标志物在理解和管理心脏性休克 (CS) 中的作用.
- 评估这些生物标志物如何提高CS患者的诊断准确性和预后评估.
主要方法:
- 对心脏性休克中非心脏生物标志物的当前文献的综述.
- 对乳酸,葡萄糖和炎症标志物的数据分析.
- 评估生物标志物提供的洞察力,超越传统的心脏评估.
主要成果:
- 越来越多的证据支持乳酸,葡萄糖和炎症标志物在CS中的实用性.
- 这些生物标志物提供了对血液代谢和细胞干扰的更深入的理解.
- 非心脏生物标志物完善诊断并提高CS的预后准确性.
结论:
- 非心脏生物标志物为心脏性休克提供了宝贵的见解.
- 它们增强了诊断和预后能力,有助于临床决策.
- 对新生物标志物的进一步研究对于CS的向治疗至关重要.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
128
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
128
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
01:24Blood Pressure Imbalances and Circulatory Shock
764
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
764
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413